If Not Us, Who? If Not Now, When?
We’ve all
heard this quote, attributed to various people, most notably John F. Kennedy.
It’s been used in a variety of contexts including other politicians. I even
used it when I served on the School Committee in my town. But it is so appropriate right now to think
about this in context of the state of research & development investment in
the United States, and in particular, basic cancer research.
I was
recently promoted to Cancer Research Evangelist at the National Foundation for Cancer Research, and in
this role I will continue to be the voice for the urgency of funding for basic
research. I am determined to keep educating the public about the work being done in laboratories today that will lead to discoveries tomorrow. I've introduced you to many of these researcher on this blog. The U.S. is falling behind on
investment in R&D to countries like China. China’s total expenditure on research and
development (R&D) has increased
by 23% a year on average over the past decade, and the central government’s
expenditure on science and technology is estimated to overtake the U.S. by 2019. I hope and
will continue to advocate for more U.S. government support of basic cancer research. Vice President Joe Biden’s Moonshot
Initiative is a positive step forward.
But more
importantly, I will continue advocating for more philanthropic support of basic
cancer research. The type of seed funding that NFCR has been providing for 43
years. Putting money directly into the laboratory, allowing scientists the freedom
and flexibility to experiment on new ideas that can lead to the next big
breakthroughs. There are so many people and institutions that have achieved
great success in our country who have resources necessary to fill the gap in
government funding. People like Oracle Founder Larry Ellison, who recently pledged
$200 million to USC to fund a cancer research center. Thank you for this
gift. #gratitude
I recently
had lunch with a brilliant researcher in Boston who told me that a gift of
$100,000 can support a young researcher on his team and the reagents necessary
to do experiments for one year. Think of the impact of $200 million? So, “if
not us, who?” Other countries like China. “If not now, when?” We will see the
impact 20 years from now if we don’t continue to make these investments now.
#CancerResearchEvangelist